Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NatiOnal Referral cenTEr Study of Transthyretin Amyloid Cardiomyopathy(ATTR) Patients on Tafamidis: Real World Prospective Study

NCT06251778 is registered in ClinicalTrials.gov with Paolo Milani as lead sponsor.

NCT NCT06251778
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06251778 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NatiOnal Referral cenTEr Study of Transthyretin Amyloid Cardiomyopathy(ATTR) Patients on Tafamidis: Real World Prospective Study
Lead sponsor
Paolo Milani
Phase
Observational
Overall status
Recruiting
Start date
January 26, 2024
Completion date
January 26, 2027
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amyloidosis, amyloidosis cardiac, attr amyloidosis wild type